0 likes | 1 Views
2025 is projected to be a record year for FDA drug approvals, with 74 novel drugs expectedu2014the most in a decade. Oncology leads with 14 treatments for various cancers. Breakthroughs include a rare disease treatment (Sebetralstat for HAE), a novel AMR drug (NAFITHROMYCIN), and a new pain relief mechanism (Suzetrigine). Healthark's report highlights these and other first-time approvals across multiple therapeutic areas, signaling a transformative year for healthcare.
E N D